Sermorelin

What is sermorelin?

Sermorelin is a GHRH analog made of the first 29 amino acids of natural growth-hormone-releasing hormone, which is the shortest fragment that still does the full job. It has the most legitimate regulatory history of any GH secretagogue here: it was FDA-approved (as Geref) in the 1990s to diagnose and treat growth-hormone deficiency in children. The branded product was pulled from the US market in 2008 for commercial reasons, not safety, and sermorelin is now prescribed through compounding pharmacies, largely off-label for age-related GH decline.

How sermorelin works

Sermorelin binds the GHRH receptor on the pituitary and prompts it to make and release your own growth hormone in a natural, pulsatile pattern. The important detail is what it does not do: it does not flood the body with outside GH. Because release still runs through the pituitary, it stays under the body's built-in brake, the hormone somatostatin, which makes runaway overdosing harder than it is with injected GH itself. That preserved feedback loop is the core of its safety argument.

What the research shows

Sermorelin is one of the most studied secretagogues in actual clinical medicine, with a real history as a pediatric GH-deficiency treatment and a diagnostic agent for pituitary function. That gives it a stronger clinical foundation than the research-only peptides. The caveat is that its modern popularity, for adult anti-aging, body composition, and sleep, runs ahead of the trial evidence. The pediatric-deficiency and diagnostic use is well established; the age-management use is mostly extrapolation and clinical experience rather than large outcome trials.

Dosage and how it is used

In anti-aging and wellness clinics, sermorelin is commonly prescribed at roughly 200 to 300 mcg by subcutaneous injection at night, timed to match the body's natural overnight GH pulse. This is off-label prescribing through compounding pharmacies rather than an FDA-approved regimen, so specifics vary by provider.

→ How to reconstitute sermorelin: calculator, units to draw & storage

Side effects and safety

Sermorelin is generally well tolerated, with the most common issues being injection-site reactions such as redness or swelling, and occasional flushing or headache. Its preserved feedback loop is a genuine safety advantage over exogenous GH. The honest framing: it has more real-world prescribing history than most peptides on this list, but its current adult wellness use is off-label, and long-term outcome data for that use is limited.

• Research depth: extensive clinical history, formerly FDA-approved. Human trials: yes.
• Works through the pituitary's own feedback brake, unlike injected GH.
• Current adult anti-aging use is off-label via compounding pharmacies. Verify status independently.

Frequently asked questions

References

• Walker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clinical Interventions in Aging, 2006.
• Sermorelin: regulatory history and pharmacology overview. Reference summary.